HomeTacrolimusTacrolimus + Olmesartan Medoxomil And Amlodipine Besylate And Hydrochloro

Does Tacrolimus Interact with Olmesartan Medoxomil And Amlodipine Besylate And Hydrochloro?

Tacrolimus and Olmesartan Medoxomil And Amlodipine Besylate And Hydrochloro have a moderate drug interaction according to U.S. FDA drug labeling data. Amlodipine increases exposure to tacrolimus. The mechanism involves cyp3a inhibition by amlodipine. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Tacrolimus Class
Calcineurin Inhibitor Immunosuppressant
Olmesartan Medoxomil And Amlodipine Besylate And Hydrochloro Class
Thiazide Diuretic
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Tacrolimus and Olmesartan Medoxomil And Amlodipine Besylate And Hydrochloro occurs because cyp3a inhibition by amlodipine. Clinically, this means amlodipine increases exposure to tacrolimus. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Tacrolimus and your doctor is considering prescribing Olmesartan Medoxomil And Amlodipine Besylate And Hydrochloro (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Tacrolimus(Astagraf)+💊 Olmesartan Medoxomil And Amlodipine Besylate And Hydrochloro(Tribenzor)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Calcineurin Inhibitor Immunosuppressant
Drug B class
Thiazide Diuretic
Source
NLP:olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide

What this means in plain English

Amlodipine increases exposure to tacrolimus.

About Tacrolimus and Olmesartan Medoxomil And Amlodipine Besylate And Hydrochloro

Tacrolimus is a Calcineurin Inhibitor Immunosuppressant, while Olmesartan Medoxomil And Amlodipine Besylate And Hydrochloro is a Thiazide Diuretic. You may recognize them by the brand names Astagraf and Tribenzor. Tacrolimus is given by intravenous (IV) infusion, whereas Olmesartan Medoxomil And Amlodipine Besylate And Hydrochloro is taken by mouth. Both Tacrolimus and Olmesartan Medoxomil And Amlodipine Besylate And Hydrochloro carry an FDA boxed warning — the agency's most serious safety designation.

What the FDA label says

"CYP3A inhibition by amlodipine"

📖 Source: NLP:olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Tacrolimus and Olmesartan Medoxomil And Amlodipine Besylate And Hydrochloro against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.